Serveur d'exploration Covid (26 mars) - Exploration (Accueil)

Index « AbsEn.i » - entrée « mortality »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
mortalities < mortality < mortem  Facettes :

List of bibliographic references indexed by mortality

Number of relevant bibliographic references: 108.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000032 (2020) X. Yuan [République populaire de Chine] ; J S Mu [République populaire de Chine] ; G X Mo [République populaire de Chine] ; X S Hu [République populaire de Chine] ; P. Yan [République populaire de Chine] ; L X Xie [République populaire de Chine][Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
000057 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000060 (2020) M L Sun [République populaire de Chine] ; J M Yang [République populaire de Chine] ; Y P Sun [République populaire de Chine] ; G H Su [République populaire de Chine][Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
000134 (2020) [Airway management of COVID-19 patients with severe pneumonia].
000178 (2020) Weier Wang [République populaire de Chine] ; Jianming Tang [République populaire de Chine] ; Fangqiang Wei [République populaire de Chine]Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.
000239 (2020) Yi-Chi Wu [République populaire de Chine] ; Ching-Sung Chen [République populaire de Chine] ; Yu-Jiun Chan [République populaire de Chine]The outbreak of COVID-19: An overview.
000310 (2020) Dandan Wu [République populaire de Chine] ; Xuexian O. Yang [États-Unis]TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.
000364 (2020) Yanis Roussel [France] ; Audrey Giraud-Gatineau [France] ; Marie-Thérèse Jimeno [France] ; Jean-Marc Rolain [France] ; Christine Zandotti [France] ; Philippe Colson [France] ; Didier Raoult [France]SARS-CoV-2: fear versus data.
000376 (2020) Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela]Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
000397 (2020) Kai Sen Tan [Singapour] ; Rachel Liyu Lim [Singapour] ; Jing Liu [Singapour] ; Hsiao Hui Ong [Singapour] ; Vivian Jiayi Tan [Singapour] ; Hui Fang Lim [Singapour] ; Kian Fan Chung [Royaume-Uni] ; Ian M. Adcock [Royaume-Uni] ; Vincent T. Chow [Singapour] ; De Yun Wang [Singapour]Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium
000412 (2020) David Baud [Suisse] ; Xiaolong Qi [République populaire de Chine] ; Karin Nielsen-Saines [États-Unis] ; Didier Musso [France] ; Léo Pomar [Suisse] ; Guillaume Favre [Suisse]Real estimates of mortality following COVID-19 infection.
000420 (2020) Ken J. Goh [Singapour] ; Mindy Cm Choong ; Elizabeth Ht Cheong ; Shirin Kalimuddin ; Sewa Duu Wen ; Ghee Chee Phua ; Kian Sing Chan ; Salahudeen Haja MohideenRapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection.
000484 (2020) Yunpeng Ji [Pays-Bas] ; Zhongren Ma [République populaire de Chine] ; Maikel P. Peppelenbosch [Pays-Bas] ; Qiuwei Pan [Pays-Bas]Potential association between COVID-19 mortality and health-care resource availability.
000490 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000503 (2020) Kollengode Ramanathan [Australie] ; David Antognini [Australie] ; Alain Combes [France] ; Matthew Paden [États-Unis] ; Bishoy Zakhary [États-Unis] ; Mark Ogino [États-Unis] ; Graeme Maclaren [Australie] ; Daniel Brodie [États-Unis] ; Kiran Shekar [Australie]Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
000517 (2020) Jieliang Chen [République populaire de Chine]Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses.
000542 (2020) Al Giwa [États-Unis] ; Akash Desai [États-Unis]Novel coronavirus COVID-19: an overview for emergency clinicians
000559 (2020) Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000597 (2020) Qin Sun [République populaire de Chine] ; Haibo Qiu [République populaire de Chine] ; Mao Huang [République populaire de Chine] ; Yi Yang [République populaire de Chine]Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province
000598 (2020) Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde]Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
000706 (2020) Shweta Saraswat ; Meenakshi Chaudhary ; Deepak SehgalHepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "mortality" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "mortality" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    mortality
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021